Many investors dream of building a portfolio that delivers significant passive income. Let's delve into a few arguments in favor of loading up on passive income stocks right now and a few in favor of holding off. One big argument in favor of buying passive income stocks right now is investors will be able to lock in more income for each invested dollar than before.
AbbVie (ABBV) closed at $141.21 in the latest trading session, marking a -1.29% move from the prior day.
A little-known group of Buffett stocks includes three members of dividend royalty with solid growth prospects.